Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Seriously?
Read the messages posted earlier today.
September 28 is the court date.
Then we wait for filing updates on OTC Markets after that as the next step.
The biggest hurdle with that will be the very first one that ties into the former company.
Yeah....the revenue section does not look correct... that's why they need an auditor...hehe.
For them to want audited financials...that does give a potential clue of a future merger which the new old guy has been referring to.
Let's see how the story unfolds in the coming months.
Per a Twitter update today...they are moving towards audited financials.
Twitter update today.
"shareholders, the attorney letter for our annual report will be filed soon. We are interviewing auditing firms and will initiate an audit of the company asap. We will provide more information on the status of the company soon and will provide regular updates going forward."
Vince,
You get a point for at least posting something on social media. That's a start. Thank you.
It's the same game screen as last month but with fancier graphics. Why are you not showing any other screen related to the discounts or navigation within the app?
Why is golf separated in its own category outside of the sports category?
The new owner did nothing with this shell. Let it become stagnant and is now on Expert Market for not keeping current with financials.
A waste of a good shell with great share structure.
Maybe one day someone else will take it over and do something with it.
The company will be releasing screenshots and additional details about the app on twitter @Pennexx.
Come on Vince. Where are the updates?
Only 1 screenshot of 1 part of the app in the past month.
Where are more screenshots and details?
SSM is irrelevant.
They were basically a broker selling stock shells to companies. Once they sold the shells, their involvement was finished.
SSM may be dissolved but that has no effect on the companies now running those former shells.
Yes...they did sell some shells to some really bad companies.
The jury is not out yet with AVVH. AVVH is just dormant from a shareholder perspective. The share structure has not changed. AVVH cannot control the public trading of the stock. The share price has not declined due to any dilution.
I have contacted the TA and they confirmed no new shares can be introduced into the float without going through them. The share structure has not increased since the merger.
Yes...there are preferred shares that can convert into commons but as you stated before, that cannot happen until some month in 2024.
We continue to wait for the story to unfold here.
Seems very risky to be buying this when they are at risk of expert market status for not filing Q2 ER.
I thought Think or Swim (TOS) was immediately available to the TDA to Schwab transfer customers?
Do you know if you are a Schwab client with access to TOS, if with TOS, you can trade OTC shares higher than the Schwab 999,999 trade limitation?
I just Googled it.
Think Or Swim (TOS) does have L2 and you get access to TOS as a Schwab user. It will be the same login as your Schwab account.
You can get the TOS app or use the web browser version.
I believe you can use Think or Swim as a Schwab user. Does TOS have L2? You can trade from it.
Yearly financials were released.
No revenue.
I remember you once said/thought Scott Sitra was going to be involved in this business.
Did he do so behind the scene?
Nothing turns out well with whatever he gets his hands on.
Anyone try or became a BETA tester of the app?
Any comments about it?
Perhaps BETA testers had to sign a NDA.
AVVH updated their Twitter address on OTC Markets on Aug 29. Public updates may be coming soon.
No. They are scheduled to have a reverse split in October. Date not set yet but there is a NASDAQ deadline around Oct 20 if my memory is correct. You can look up the filings.
Cooley is unpopular because he sold multiple shells to bad companies. Cooley is motivated by money.
The fact that he remains with AVVH means he sees the potential to make money here. Otherwise he would not be hanging around as Secretary of AVVH.
Why you calling me out on Myrtle? I've never even talked about Myrtle. I don't know a thing about Myrtle or could care less about it.
I've referenced the discrepancy of the O/S.
If the CEO is not lying or hiding the true O/S...why is there a gag on updating the information by the TA on OTC Markets?
Hmmmmm
Where are the FTDs?
Have you gone to this site which shows the "real" shorting of a stock?
https://otce.finra.org/otce/equityShortInterest
Show me where RNVA has short positions....LOL
If you reference the daily OTC short report website...then that just proves you don't understand real short scenarios.
Instead of throwing out insults why don't you address the fact of the O/S being higher but not being updated on OTC Markets.
Seems I was correct and instead of saying so, you redirect to insults. Very mature of you...NOT
People love to throw out a naked short theory but cannot prove it. Makes for an easy story.
Why would anyone be shorting RNVA when it has reached bottom? It cannot go any lower than it is now. Shorting..whether real or fake...does not make any sense now.
P.S. the 30B O/S has been updated to almost double now.
Even Jmoney is saying the O/S is 58 Billion now.
An "un"audited quarterly financial showed no change in O/S but have you stopped to think why the Transfer Agent has not updated the OTC Markets website? The TA been told not to.
The TA cannot lie and therefore have not updated the date and real numbers.
The O/S on an "un"audited financial can be whatever the CEO wants it to be.
The explanation...sort of...was released today.
Funny how the PR is dated Aug 21 but is released today.
Aluf Holdings Announces Termination of Chief Executive Officer and the Initiation of a Search for a New Chief Executive Officer
Press Release | 08/31/2023
FORT LAUDERDALE, FL., August 21, 2023 : Aluf Holdings, Inc. (OTC PINK: AHIX) today announced that the Board of Directors of the Company has terminated Sam M. Jakobs, the Chief Executive Officer of the Company, effective August 1, 2023. According to his employment agreement, Mr. Jakobs was an at will employee and was therefore terminated without cause. Mr. Jakobs termination is not due to any disagreement with the Company regarding its financial reporting, policies or practices or any potential fraud relating thereto. He will not receive any severance payment and Alufs previously announced plans to acquire BizzUniverse and Bizz Shield Pro have also been terminated.
In order to ensure continuity going forward, the Company has appointed a leadership group to share the duties of the office of the CEO until a new leader is named. Those appointed include: Teresa McWilliams, Chief Financial Officer, Dr. Aditya Ganguli, CPA, Director of Corporate Affairs and M&A, and Larry G. Striggles, Director of Accounting and Financial Reporting.
Waiting for the next catalyst.
Revealing the app to the world!!!
AVVH is getting ready behind the scene. It is just happening super slow.
Miguel has twice publicly mentioned Gold Quest Capital on televised interviews and even mentioned Gold Quest Capital being a publicly traded stock.
Do you have any thoughts about why the CEO gifted preferred shares to his employees?
To me, that is a sign of him wanting his employees to be a part of the future success of the company. I believe the curtain will be pulled back and something will be revealed soon.
Yeah...I don't see where the $145k is reported.
362,500 * $0.40
False in what way?
AVVH made some changes to the OTC Markets website:
Added the Gold Quest Capital website link
Added a new company officer to the list of names.
Modified the Business Description to include "syndicating first lien".
Annual report has been released.
https://www.otcmarkets.com/stock/AVVH/disclosure
Oh no.... hope not another reason for a further delayed launch.
What was the O/S or float of DPLS when it went from trips to .19?
Another obstacle with today's OTC trading market is the volume has dried up.
I believe it will be harder to see the multiplier gains of past years in today's economy.
He did tweet a photo of a game part of the app about 2 weeks ago.
You want him to tweet 2x in the same month?
That is asking a lot from him...LOL.
You were not wrong about the compensation.
Per the offering details just released......how can he justify such large compensation expense when absolutely "nothing" happened in 2022.
I suppose Ira received a nice bonus to join ENDV late in 2022.
Our operating expenses increased by $1,105,038 or 48.4% to $3,389,705 in 2022 compared to $2,284,667 in 2021. The operating expenses were comprised primarily of consulting fees, professional fees, and stock-based compensation. This change was due primarily to an increase in stock-based compensation of approximately $1.2 million.
ENDV has filed a preliminary offering.
Endonovo Therapeutics Inc., a Delaware corporation (the “Company”, “ENDV”, “we”, or “our”), is offering up to a maximum of 220,000,000 shares (the “Maximum Amount”) of our Common Stock, par value $0.0001 per share (the “Shares”) to be sold in this offering (the “Offering”). The Shares are tentatively being offered at a purchase price of $0.01 per Share, for gross proceeds of up to $5,000,000 (the “Maximum Amount”), pursuant to this Offering Circular (this “Offering Circular”). Before this Offering is qualified, the Company will pick a final price for the shares (the “Offering Price”) which we anticipate will be between $0.01 and $0.05 per share.
How about Black Friday deals!!!!
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
Los Angeles, CA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) -- a US-based commercial medical device company -- today announced its inclusion on the Federal Supply Schedule (FSS) for SofPulse® Pulsed Electro Magnetic Field (PEMF) medical devices for distribution throughout the Federal healthcare supply channels.
The listing was spearheaded by Endonovo’s partner, Academy Medical Inc, a Service-Disabled Veteran-Owned Small Business (SDVOSB) government reseller. Academy Medical’s efforts to secure SofPulse® on the exclusive FSS is the first of many strategic moves for Endonovo to streamline the distribution of its medical products throughout government healthcare systems.
Expanding Distribution for FDA-Cleared Surgical Solutions
SofPulse® is an FDA-Cleared medical device which is recognized for its exceptional efficacy for postoperative reduction of pain and edema (inflammation). Clinical studies and patient use have shown that PEMF has the capacity to alleviate pain, promote recovery and enhance overall patient well-being. As SofPulse® is non-invasive, opioid-free and with its potential to speed up recovery, it sets it apart in the medical technology landscape.
The inclusion of SofPulse® on the FSS signifies not only a stamp of approval from Federal authorities, but further affirms the Company’s objective of having SofPulse® widely distributed within the government healthcare sectors.
"This endorsement reaffirms our commitment to delivering cutting-edge solutions that cater to diverse healthcare needs” according to Ira Weisberg, President of Endonovo’s Medical Division. Listing on the FSS is a testament to the efficacy and potential of SofPulse® within the U.S. and global medical community,” he pointed out.
SofPulse® Positioned for Accelerated Revenue Growth
SofPulse® listing on the FSS places its proven PEMF recovery technology at the forefront of distribution, paving the way for exponential growth within the Veterans Administration (VA) and Department of Defense as well as other governmental healthcare sectors. The VA utilizes the FSS to make available a wide range of authorized products and services on an ongoing basis.
“Securing a coveted place on the prestigious FSS for SofPulse® PEMF products is a significant milestone and will help us expand our distribution, growth and revenues from our government healthcare contracts,” Weisberg said.
Opportunity to Capitalize on Untapped PEMF Market
The FSS was established as a means of streamlining government purchases of commercial products. Having SofPulse® included in the FSS will provide for expanded opportunities for the distribution of the Company’s innovative PEMF products throughout the VA healthcare system, which services over 16.5 million patients yearly. Inclusion in the FSS offers companies like Endonovo the opportunity to distribute and generate revenue through sales and distribution to the VA, Department of Defense, Federal and executive agencies in addition to other healthcare agencies.
As Endonovo navigates this new phase of Federal expansion, the Company remains resolute in its mission to enhance patient care for our military heroes and their families. Expanding Federal contracts is important to positioning Endonovo to seize anticipated expansion for active and non-active military personnel surgical, medical and wound care needs. Through the FSS, SofPulse® will gain increased visibility to serve a wider range of patients., strengthening its position as a non-opioid medical solution within the Government medical technology sector.
Plans for Future Expansion of Government Contracts
Endonovo has identified numerous governmental healthcare contracts for the expansion of distribution throughout the government healthcare sectors. Through Academy Medical, additional future government contracts targeted include: Strategic Acquisition Center (SAC), National Acquisition Center (NAC) and the defense agencies and Department of Defense Field Activities (DAFA) distribution schedules. Each federal contract being targeted affords Endonovo the opportunity allows Endonovo and SofPulse to reach a broader audience, including hundreds of federal healthcare facilities throughout the US and the world. The Company aims to leverage the power and influence of the Federal government's buying process to provide SofPulse® to healthcare facilities and patients not currently being serviced.
Weisberg concluded: “To streamline our government distribution expansion, we have established pre-negotiated prices, terms, deliverables, warranties and other details to aid in making the purchasing process more straightforward. Our Company is starting to realize the benefits of our partnership with Academy Medical with being able to service new distribution channels as well as increased revenue.”
About Endonovo Therapeutics, Inc.
Endonovo Therapeutics is currently structured into two divisions: Legacy – a commercial-stage developer primarily of noninvasive wearable Electroceuticals® therapeutic devices for pain relief, general wellness and wound curatives with many of its products marketed under the SofPulse® brand name; and its Build Up Strategy – acquiring complementary specialty service providers in the medical technology and construction industries.
About Academy Medical, Inc.
Academy Medical is a premier Service-Disabled Veteran-Owned Small Business and distributor of medical-surgical equipment and supplies to the Federal government. As a government procurement partner with industry expertise and access to advanced technology, Academy Medical’s mission is to leverage its preferred status as an SDVOSB to create a streamlined, more cost-effective process for its government customers and supplier partners.
Academy Medical is headquartered in West Palm Beach, Florida. Learn more about partnering with the company in its service-driven business at www.academymedical.net.
I am not tracking their financials...but here is a generic reply.
Is it possible that Cost of Goods was low one Q due to selling existing inventory and then it increased next Q as they re-ordered supply for future orders?
2Q is out. $45K in sales for Q2